Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.46 USD | +0.22% | -1.11% | -10.78% |
05-30 | Stifel Starts Abeona Therapeutics With Buy Rating, $21 Price Target | MT |
05-16 | Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.78% | 183M | |
+46.73% | 56.87B | |
+37.52% | 39.72B | |
-5.71% | 39.27B | |
-4.42% | 28.73B | |
+13.60% | 26.21B | |
-16.64% | 19.79B | |
+32.71% | 12.28B | |
+26.94% | 12.23B | |
+1.51% | 12.12B |
- Stock Market
- Equities
- ABEO Stock
- News Abeona Therapeutics Inc.
- Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating